Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 17;27(16):5257.
doi: 10.3390/molecules27165257.

Cycloaddition of 4-Acyl-1 H-pyrrole-2,3-diones Fused at [ e]-Side and Cyanamides: Divergent Approach to 4 H-1,3-Oxazines

Affiliations

Cycloaddition of 4-Acyl-1 H-pyrrole-2,3-diones Fused at [ e]-Side and Cyanamides: Divergent Approach to 4 H-1,3-Oxazines

Ekaterina E Khramtsova et al. Molecules. .

Abstract

4-Acyl-1H-pyrrole-2,3-diones fused at [e]-side with a heterocyclic moiety are suitable platforms for the development of a hetero-Diels-Alder-reaction-based, diversity-oriented approaches to series of skeletally diverse heterocycles. These platforms are known to react as oxa-dienes with dienophiles to form angular 6/6/5/6-tetracyclic alkaloid-like heterocycles and are also prone to decarbonylation at high temperatures resulting in generation of acyl(imidoyl)ketenes, bidentate aza- and oxa-dienes, which can react with dienophiles to form skeletally diverse products (angular tricyclic products or heterocyclic ensembles). Based on these features, we have developed an approach to two series of skeletally diverse 4H-1,3-oxazines (tetracyclic alkaloid-like 4H-1,3-oxazines and 5-heteryl-4H-1,3-oxazines) via a hetero-Diels-Alder reaction of 4-acyl-1H-pyrrole-2,3-diones fused at [e]-side with cyanamides. The products of these transformations are of interest for drug discovery, since compounds bearing 4H-1,3-oxazine moiety are extensively studied for inhibitory activities against anticancer targets.

Keywords: 4H-1,3-oxazine; acyl(quinoxalin-2-yl)ketene; cyanamide; cycloaddition; hetero-Diels–Alder reaction; heterocumulene; thermolysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
4H-1,3-Oxazine based inhibitors and their 4H-pyran analogs.
Scheme 1
Scheme 1
Modes of participation of FPDs 1 as heterodienes in HDA.
Scheme 2
Scheme 2
Plausible pathway of formation of compounds 4 and G.

References

    1. Burke M.D., Schreiber S.L. A Planning Strategy for Diversity-Oriented Synthesis. Angew. Chem. Int. Ed. 2004;43:46–58. doi: 10.1002/anie.200300626. - DOI - PubMed
    1. Gerry C.J., Schreiber S.L. Recent achievements and current trajectories of diversity-oriented synthesis. Curr. Opin. Chem. Biol. 2020;56:1–9. doi: 10.1016/j.cbpa.2019.08.008. - DOI - PubMed
    1. Schreiber S.L. Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery. Science. 2000;287:1964–1969. doi: 10.1126/science.287.5460.1964. - DOI - PubMed
    1. Galloway W.R., Isidro-Llobet A., Spring D. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nat. Commun. 2010;1:80. doi: 10.1038/ncomms1081. - DOI - PubMed
    1. Morrison R., Al-Rawi J.M.A. Synthesis, structure elucidation, DNA-PK, PI3K, anti-platelet and anti-bacteria activity of linear 5, 6, and 10-substituted-2-morpholino-chromen-oxazine-dione and angular 3, 4, 6-substituted-8-morpholino-chromen-oxazine-2,10-dione. J. Enzym. Inhib. Med. Chem. 2016;31:86–95. doi: 10.1080/14756366.2016.1190710. - DOI - PubMed

LinkOut - more resources